News release Notification of sales tie-up and release of GlashVista® cutaneous solution 0.03% 5 mL for eyelash hypotrichosis treatment in Japan On August 28, 2014, Allergan Japan KK (Head Office: Tokyo, President: Leo Y Lee; hereafter ... 4 Traders, 4 hours ago
TOKYO/JAKARTA -- Pharmaceutical companies have largely been unwilling to develop vaccines and treatment for dengue fever, citing small demand due to the disease primarily occurring in emerging nations. But as the disease spreads, with the current ...Nikkei Asian Review, 1 hour ago
TIDMPLE RNS Number : 7696R Plethora Solutions Holdings PLC 16 September 2014 16 September 2014 Plethora Solutions Holdings PLC ("Plethora" or the "Company") Plethora Signs Licensing Agreement with Recordati to commercialise PSD502(TM), a ...ADVFN UK, 4 hours ago
16 September 2014 Plethora Solutions Holdings PLC ("Plethora" or the "Company") Plethora Signs Licensing Agreement with Recordati to commercialise PSD502,a novel treatment for premature ejaculation Plethora expected to receive ...TrustNet, 4 hours ago
on your WebpageAdd Widget >Get your members hooked!